Clinical Trials Directory

Trials / Unknown

UnknownNCT06163911

In-depth ECG Analysis for the Extraction of Biomarkers of Cardiac Mechanical Dispersion

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers

Summary

Left ventricular systolic dysfunction (LVSD) refers to impaired contraction of the left ventricle, and can lead to heart failure and death. Early identification of LVSD, which often remains asymptomatic for years, is therefore crucial to mitigate the associated risks through appropriate treatment. Echocardiographic screening of asymptomatic individuals is costly, requires access to experts, and the criteria for selecting potential high-risk individuals for screening remain unclear. Unlike echocardiography, the electrocardiogram (ECG) is a relatively low-cost procedure, routinely available and requiring little technical training to set up the examination and collect data, making it an interesting tool for early detection of LVSD.

Conditions

Interventions

TypeNameDescription
DEVICEECGRoutine care 12-lead electrocardiogram
DEVICEEchocardiographyRoutine care echocardiography

Timeline

Start date
2023-12-01
Primary completion
2024-11-30
Completion
2025-06-01
First posted
2023-12-11
Last updated
2023-12-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06163911. Inclusion in this directory is not an endorsement.

In-depth ECG Analysis for the Extraction of Biomarkers of Cardiac Mechanical Dispersion (NCT06163911) · Clinical Trials Directory